Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,064 | 316 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,330 | 80 | $0 (2024) |
| Alkermes, Inc. | $619.69 | 31 | $0 (2024) |
| Lundbeck LLC | $553.97 | 26 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $461.59 | 24 | $0 (2024) |
| ITI, Inc. | $437.21 | 20 | $0 (2023) |
| Corium, LLC | $405.72 | 20 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $282.18 | 13 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $265.49 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $237.70 | 13 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $220.61 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,623 | 87 | ABBVIE INC. ($452.20) |
| 2023 | $2,008 | 103 | ABBVIE INC. ($497.45) |
| 2022 | $1,476 | 77 | ABBVIE INC. ($224.35) |
| 2021 | $957.30 | 49 | Janssen Pharmaceuticals, Inc ($216.09) |
All Payment Transactions
316 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Central Nervous System | ||||||
| 12/11/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: CNS | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.24 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: CNS | ||||||
| 11/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/30/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: CNS | ||||||
| 10/29/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/25/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: ADHD | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: ADHD | ||||||
| 09/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.20 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $23.82 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 09/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: ADHD | ||||||
| 09/09/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: CNS | ||||||
| 08/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 206 | 594 | $119,844 | $43,734 |
| 2022 | 3 | 200 | 505 | $100,159 | $36,724 |
| 2021 | 3 | 208 | 405 | $61,994 | $26,650 |
| 2020 | 4 | 339 | 545 | $57,388 | $21,024 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 123 | 451 | $90,200 | $33,454 | 37.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 46 | 46 | $15,870 | $5,445 | 34.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 97 | $13,774 | $4,835 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 117 | 361 | $72,200 | $26,441 | 36.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 37 | 37 | $12,765 | $5,187 | 40.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 107 | $15,194 | $5,096 | 33.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 89 | 218 | $40,426 | $17,573 | 43.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 51 | 93 | $11,746 | $5,184 | 44.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 68 | 94 | $9,822 | $3,894 | 39.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 76 | 122 | $13,781 | $6,243 | 45.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 75 | 118 | $13,543 | $5,630 | 41.6% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 91 | 170 | $19,260 | $4,653 | 24.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 97 | 135 | $10,805 | $4,497 | 41.6% |
About Lera Kasseroler, GNP
Lera Kasseroler, GNP is a Gerontology healthcare provider based in Beaumont, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821032665.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lera Kasseroler, GNP has received a total of $6,064 in payments from pharmaceutical and medical device companies, with $1,623 received in 2024. These payments were reported across 316 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($6,064).
As a Medicare-enrolled provider, Kasseroler has provided services to 953 Medicare beneficiaries, totaling 2,049 services with total Medicare billing of $128,131. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Gerontology
- Other Specialties Psychiatric/Mental Health
- Location Beaumont, TX
- Active Since 06/15/2006
- Last Updated 03/13/2015
- Taxonomy Code 363LG0600X
- Entity Type Individual
- NPI Number 1821032665
Products in Payments
- VRAYLAR (Drug) $1,312
- REXULTI (Drug) $727.97
- CAPLYTA (Drug) $513.06
- TRINTELLIX (Drug) $423.57
- LYBALVI (Drug) $403.24
- Azstarys (Drug) $327.21
- JORNAY PM (Drug) $265.49
- ARISTADA (Drug) $216.45
- Dyanavel XR (Drug) $215.68
- INGREZZA (Drug) $173.92
- INVEGA SUSTENNA (Drug) $166.87
- LATUDA (Drug) $145.73
- Auvelity (Drug) $131.29
- AUSTEDO (Drug) $127.43
- APLENZIN (Drug) $114.14
- Austedo XR (Drug) $93.18
- QUVIVIQ (Drug) $85.14
- BELSOMRA (Drug) $82.26
- AZSTARYS (Drug) $78.51
- FANAPT (Drug) $73.39
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gerontology Doctors in Beaumont
Mr. Zeus Arco, Nurse Practitioner, NURSE PRACTITIONER
Gerontology — Payments: $13,079
Shewana Spencer, Np, NP
Gerontology — Payments: $2,635
Shari Miles, Aprn, APRN
Gerontology — Payments: $2,514
Mrs. Ashley Cox-Rion, Rn- Ggnp, RN- GGNP
Gerontology — Payments: $1,019
Falon Richard, Aprn-Cnp, APRN-CNP
Gerontology — Payments: $290.63
Dennis Alphonsus Chua, Otr/L, OTR/L
Gerontology